635 related articles for article (PubMed ID: 19892420)
1. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
[TBL] [Abstract][Full Text] [Related]
2. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
[TBL] [Abstract][Full Text] [Related]
4. [Cervical lymphatic metastases from occult primary tumor. A nation-wide 20-year study from the Danish society of head and neck oncology].
Grau C; Johansen LV; Jakobsen J; Geertsen PF; Andersen EV; Jensen BB
Ugeskr Laeger; 2001 Mar; 163(10):1432-6. PubMed ID: 11257752
[TBL] [Abstract][Full Text] [Related]
5. Role of radiotherapy in the treatment of cervical lymph node metastases from an unknown primary site: retrospective analysis of 113 patients.
Beldì D; Jereczek-Fossa BA; D'Onofrio A; Gambaro G; Fiore MR; Pia F; Chiesa F; Orecchia R; Krengli M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1051-8. PubMed ID: 17716824
[TBL] [Abstract][Full Text] [Related]
6. Surgery with complete resection improves survival in radiooncologically treated patients with cervical lymph node metastases from cancer of unknown primary.
Hauswald H; Lindel K; Rochet N; Debus J; Harms W
Strahlenther Onkol; 2008 Mar; 184(3):150-6. PubMed ID: 18330511
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy for cervical lymph node metastases from unknown primary cancer.
Madani I; Vakaet L; Bonte K; Boterberg T; De Neve W
Int J Radiat Oncol Biol Phys; 2008 Jul; 71(4):1158-66. PubMed ID: 18258383
[TBL] [Abstract][Full Text] [Related]
8. Is planned neck dissection necessary for head and neck cancer after intensity-modulated radiotherapy?
Yao M; Hoffman HT; Chang K; Funk GF; Smith RB; Tan H; Clamon GH; Dornfeld K; Buatti JM
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):707-13. PubMed ID: 17379453
[TBL] [Abstract][Full Text] [Related]
9. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
[TBL] [Abstract][Full Text] [Related]
10. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
11. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiotherapy for cervical node squamous cell carcinoma metastases from unknown head-and-neck primary site: M. D. Anderson Cancer Center outcomes and patterns of failure.
Frank SJ; Rosenthal DI; Petsuksiri J; Ang KK; Morrison WH; Weber RS; Glisson BS; Chao KS; Schwartz DL; Chronowski GM; El-Naggar AK; Garden AS
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1005-10. PubMed ID: 20207504
[TBL] [Abstract][Full Text] [Related]
13. Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell carcinoma.
Maulard C; Housset M; Brunel P; Huart J; Ucla L; Rozec C; Delanian S; Baillet F
Laryngoscope; 1992 Aug; 102(8):884-90. PubMed ID: 1495353
[TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.
Klem ML; Mechalakos JG; Wolden SL; Zelefsky MJ; Singh B; Kraus D; Shaha A; Shah J; Pfister DG; Lee NY
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1100-7. PubMed ID: 17980501
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?
Zhao KL; Ma JB; Liu G; Wu KL; Shi XH; Jiang GL
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):446-51. PubMed ID: 20004527
[TBL] [Abstract][Full Text] [Related]
16. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and management of squamous cell carcinoma of the head and neck region with unknown primary. A survey of 167 patients].
Issing WJ; Taleban B; Tauber S
Laryngorhinootologie; 2003 Sep; 82(9):659-65. PubMed ID: 14517763
[TBL] [Abstract][Full Text] [Related]
18. Neck lymph node metastases from an unknown primary tumor retrospective study and review of literature.
Christiansen H; Hermann RM; Martin A; Nitsche M; Schmidberger H; Pradier O
Strahlenther Onkol; 2005 Jun; 181(6):355-62. PubMed ID: 15925977
[TBL] [Abstract][Full Text] [Related]
19. Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy.
Boscolo-Rizzo P; Gava A; Da Mosto MC
Ann Surg Oncol; 2007 May; 14(5):1575-82. PubMed ID: 17508250
[TBL] [Abstract][Full Text] [Related]
20. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]